Regencell's stock has been quite a rollercoaster lately, with frequent double-digit percentage swings. Those without positions enjoy the show, while those who bought in experience a wild ride. Arm initially planned to cash in on retail investors, but chickened out before earnings, losing 40% in three months—a textbook case of deleveraging. No matter how enticing the tech dream is, you must withstand volatility. For those who don’t want to be tossed around by the market, it’s best to watch and wait during this phase.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
